gb-115 and Immunologic-Deficiency-Syndromes

gb-115 has been researched along with Immunologic-Deficiency-Syndromes* in 1 studies

Other Studies

1 other study(ies) available for gb-115 and Immunologic-Deficiency-Syndromes

Article	Year
Immunocorrecting properties of GB-115 dipeptide. Bulletin of experimental biology and medicine, 2008, Volume: 145, Issue:5 We studied the effects of a new dipeptide with anxiolytic activity (GB-115, N-phenylhexanoyl-glycyl-L-tryptophan amide) on parameters of the immune in intact mice and in animals with secondary immunodeficiency caused by cyclophosphamide. GB-115 in doses of 0.1-10 mg/kg stimulated phagocytic activity of peritoneal macrophages and humoral immune response in intact mice. GB-115 exhibited immunocorrecting activity in animals with secondary immunodeficiency. Topics: Animals; Antibody Formation; CD4-CD8 Ratio; Cyclophosphamide; Dipeptides; Immunologic Deficiency Syndromes; Immunologic Factors; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Phagocytosis	2008

Article

Year

Immunocorrecting properties of GB-115 dipeptide.

Bulletin of experimental biology and medicine, 2008, Volume: 145, Issue:5

We studied the effects of a new dipeptide with anxiolytic activity (GB-115, N-phenylhexanoyl-glycyl-L-tryptophan amide) on parameters of the immune in intact mice and in animals with secondary immunodeficiency caused by cyclophosphamide. GB-115 in doses of 0.1-10 mg/kg stimulated phagocytic activity of peritoneal macrophages and humoral immune response in intact mice. GB-115 exhibited immunocorrecting activity in animals with secondary immunodeficiency.

Topics: Animals; Antibody Formation; CD4-CD8 Ratio; Cyclophosphamide; Dipeptides; Immunologic Deficiency Syndromes; Immunologic Factors; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Phagocytosis

2008